Clinical Trial

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study is a prospective, randomized, parallel-controlled clinical trial, primarily aimed at evaluating the level of body weight improvement of megestrol acetate combined with standard treatment compared with standard treatment in the first-line treatment of non-small cell lung cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-12.
Trial Details
NCT Number NCT07477808
Lead Sponsor Hunan Province Tumor Hospital
Conditions Non-small Cell Lung Cancer
Enrollment 116 participants
Start Date 2026-04-01
Primary Completion 2028-04-01 (estimated)
Study Completion 2029-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-23